education organization

University of Bath

GB

People

Connected researchers

Amelia BrownExact authorship link Amir EnglundORCID 0000-0002-2478-209X Annabel BurnleyORCID 0000-0002-1354-7043 Barbara Kasprzyk‐HordernORCID 0000-0002-6809-2875 Chloe BurkeORCID 0000-0001-7941-4721 Christopher EcclestonORCID 0000-0003-0698-1543 Claudia JardimORCID 0009-0005-3096-6601 Daniel Ying-Heng HuaORCID 0000-0003-1942-4957 David J. HealORCID 0000-0002-6128-9632 Elle WadsworthORCID 0000-0003-0797-8493 Emma FisherORCID 0000-0001-8980-3181 Esther WaltonORCID 0000-0002-0935-2200 Gemma MJ TaylorORCID 0000-0003-2185-0162 George StothartORCID 0000-0003-1323-1580 Jonas LangeORCID 0000-0001-7238-3344 Katherine SawyerORCID 0000-0001-5194-0068 Kat PetrilliORCID 0000-0001-9801-1442 Leonie Sarah BroseORCID 0000-0001-6503-6854 L HinesExact authorship link Lindsey HinesORCID 0000-0001-5052-3182 Martine SkumlienORCID 0000-0003-3552-2653 M. Begoña Delgado-CharroORCID 0000-0002-2233-7654 Michael T. LynskeyORCID 0000-0001-9989-737X Rachel Ann BarryORCID 0000-0003-1683-7895 Rachel LeesORCID 0000-0003-4787-1789 R StanbridgeExact authorship link Sam CraftORCID 0000-0002-5663-2731 Tom P. FreemanORCID 0000-0002-5667-507X Tom P. FreemanExact authorship link T P FreemanExact authorship link

Public evidence

56 connected articles

Examining the independent roles of cannabis use and tobacco use in depression risk: a multivariable Mendelian randomisation study2024 · medRxiv Associations of cannabis use, tobacco use and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis2023 · medRxiv The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controls2026 · PubMed Central Open Access Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark.2026 · Europe PMC Cannabis products and risk perceptions among people who consume and do not consume cannabis in the UK: findings from the International Cannabis Policy Study.2026 · Europe PMC Health education interventions to reduce cannabis and tobacco smoking-related harms among people who use cannabis: a systematic review.2026 · Europe PMC Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study.2025 · Europe PMC Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.2025 · Europe PMC Association of childhood mental health and cognition with longitudinal patterns of cannabis problems in adolescence.2025 · Europe PMC The impact of childhood trauma and cannabis use on paranoia: a structural equation model approach.

Registered research

Connected studies

A Phase IIa/b, Randomised, Double-blind, Placebo-controlled, Single-site, Parallel Group Clinical Trial to Examine Cannabidiol (CBD) as a Pharmacological Treatment for Cannabis Dependence.nct02044809 Do Adolescents and Adults Differ in Their Acute Subjective, Behavioural and Neural Responses to Cannabis, With and Without Cannabidiol?nct04851392 Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Studynct04605393 Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosisnct07245212

Matched by exact identifiers only. Profile data: OpenAlex.

2025 · Europe PMC

Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations.2025 · Europe PMC

Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents.2025 · Europe PMC

Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology?2025 · Europe PMC

Methylomic signature of current cannabis use in two first-episode psychosis cohorts.2025 · Europe PMC

Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits.2025 · Europe PMC

The Regulatory Environment Surrounding Cannabis Medicines in the EU, the USA, and Australia.2025 · Europe PMC

Self-Reported Cannabis Prices and Expenditures From Legal and Illegal Sources Five Years After Legalisation of Non-Medical Cannabis in Canada.2025 · Europe PMC

Does maternal education moderate the relationship between adolescent cannabis use and mental health in early adulthood?2024 · Europe PMC

The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMC

A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol.2024 · Europe PMC

Challenges achieving horizontal coherence across health and public security policies in formulating Uruguay's cannabis regulation.2024 · Europe PMC

Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks.2024 · Europe PMC

A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.2024 · Europe PMC

A proof-of-concept analysis of data from the first NHS clinic for young adults with comorbid cannabis use and psychotic disorders.2024 · Europe PMC

The acute effects of cannabis, with and without cannabidiol, on attentional bias to cannabis related cues: a randomised, double-blind, placebo-controlled, cross-over study.2024 · Europe PMC

Incident psychotic experiences following self-reported use of high-potency cannabis: Results from a longitudinal cohort study.2024 · Europe PMC

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder.2023 · Europe PMC

Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder.2023 · PubMed Central Open Access

Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence.2023 · PubMed Central Open Access

Commentary on Allaf et al.: Comparing countries with different legal cannabis markets can inform on the impact of regulating product type and potency.2023 · Europe PMC